EUVIMEDEUVIMED entdecken
Crossref

CRISPR/Cas12a-Enabled Amplification-Free Colorimetric Visual Sensing Strategy for Point-of-Care Diagnostics of Biomarkers

Zhe Zhao, Qing Xiong, Yan Zhu, Cong Zhang, Zhixin Li iD, Zhonghui Chen, Ying Zhang, Xiaoyu Deng, Yingzhou Tao iD, Shaohua Xu iD

Analytical Chemistry · 14.01.2025 · 97 (1) · 1019-1027

DOI: 10.1021/acs.analchem.4c06196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 19.12.2024. Verfasst von Zhe Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center & Jiangxi Engineering Research Center for Translational Cancer Technology, Jiangxi University of Chinese Medicine & Jiangxi Pr…. Hauptthemen laut MEDLINE: Colorimetry, CRISPR-Cas Systems, Biosensing Techniques, Point-of-Care Testing. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Education Department of Jiangxi Province, National Natural Science Foundation of China, Jiangxi University of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColorimetryCRISPR-Cas SystemsBiosensing TechniquesPoint-of-Care TestingBRCA1 ProteinPoint-of-Care SystemsBiomarkers, TumorHumansGoldMetal NanoparticlesHorseradish PeroxidaseBiomarkersBenzidinesBacterial ProteinsEndodeoxyribonucleasesCRISPR-Associated Proteins

Substanzen

GoldBRCA1 ProteinBRCA1 protein, humanHorseradish Peroxidase3,3',5,5'-tetramethylbenzidineBiomarkersBiomarkers, TumorBenzidinesCas12a proteinBacterial Proteins

Autor:innen und Institutionen

  • Cancer Research Center & Jiangxi Engineering Research Center for Translational Cancer Technology, Jiangxi University of Chinese Medicine & Jiangxi Province Key Laboratory for Diagnosis, Treatment and Rehabilitation of C…
  • College of Acupuncture and Tuina Nanjing, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.
  • Institute for Advanced Study, Research Center for Differentiation and Development of TCM Basic Theory, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi 330004, China.
  • Central Laboratory, Affiliated Hospital of Putian University, Putian University, Putian 351100, China.
  • Central Laboratory, Fujian Key Laboratory of Precision Medicine for Cancer, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian 350005, China.
  • Ministry of Education Key Laboratory of Modern Preparation of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi 330004, China.

ORCID-Profile: Zhixin Li, Yingzhou Tao, Shaohua Xu

Förderung

  • Education Department of Jiangxi Province
  • National Natural Science Foundation of China
  • Jiangxi University of Traditional Chinese Medicine
  • Natural Science Foundation of Jiangxi Province

Zitieren

APA

Zhao, Z., Xiong, Q., Zhu, Y., Zhang, C., Li, Z., Chen, Z., Zhang, Y., Deng, X., Tao, Y., & Xu, S. (2025). CRISPR/Cas12a-Enabled Amplification-Free Colorimetric Visual Sensing Strategy for Point-of-Care Diagnostics of Biomarkers. Analytical Chemistry, 97(1), 1019-1027. https://doi.org/10.1021/acs.analchem.4c06196

Vancouver

Zhao Z, Xiong Q, Zhu Y, Zhang C, Li Z, Chen Z, et al. CRISPR/Cas12a-Enabled Amplification-Free Colorimetric Visual Sensing Strategy for Point-of-Care Diagnostics of Biomarkers. Analytical Chemistry. 2025;97(1):1019-1027. doi:10.1021/acs.analchem.4c06196

BibTeX
@article{Zhao2025,
  author = {Zhao, Zhe and Xiong, Qing and Zhu, Yan and Zhang, Cong and Li, Zhixin and Chen, Zhonghui and Zhang, Ying and Deng, Xiaoyu and Tao, Yingzhou and Xu, Shaohua},
  title = {CRISPR/Cas12a-Enabled Amplification-Free Colorimetric Visual Sensing Strategy for Point-of-Care Diagnostics of Biomarkers},
  journal = {Analytical Chemistry},
  year = {2025},
  volume = {97},
  number = {1},
  pages = {1019--1027},
  doi = {10.1021/acs.analchem.4c06196}
}
Kostenlos starten →